Company / Gross Margin
Bio-Techne Gross Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
64.8%
FY2025
5-year range
64.8% / 68.0%
FY2021-FY2025
Trend
-2.4%
vs FY2024
Sector context
#33 of 96
Health Care
What the data says
At 64.8%, Bio-Techne's gross margin ranks #33 of 96 in the Health Care sector. Gross Margin remained relatively stable over the past 10 years, with values between 64.8% and 68.0%.
Based on SEC 10-K filings.
64.8% in FY2025 with a 5-year CAGR of -0.6%.
Declined from 68.0% to 64.8% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- -0.6pp
- 5-Year Change
- -0.6pp
- 10-Year Change
- -
Sector benchmark
#33 of 96 in Health CareTop 34% of 96This company 64.8% Sector average 53.6%
▼
+20.9% above sector average
Key checks
Key Insights
- In FY2025, gross margin decreased 2.4% year-over-year.
- Currently 11.2pp above the Health Care sector average.
- Peak gross margin was recorded in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 64.8% | -2.4% |
| FY2024 | 66.4% | -2.3% |
| FY2023 | 68.0% | +3.9% |
| FY2022 | 65.4% | -1.4% |
| FY2021 | 66.3% | +1.4% |
| FY2020 | 65.4% | -1.4% |
| FY2019 | 66.3% | -1.3% |
| FY2018 | 67.2% | +1.0% |
| FY2017 | 66.5% | -1.4% |
| FY2016 | 67.5% | -0.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026